SCHEMBL9235

SCHEMBL9235

[O-][S+]1CCNCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL18526747 0.96
Hydrochloric Acid SCHEMBL25288112 0.96 HIF1A (0.33)
Hydrochloric Acid SCHEMBL564662 0.96
SCHEMBL2621588 0.87
SCHEMBL256778 0.79
Hydrogen Sulfide SCHEMBL10340661 0.76
SCHEMBL10340663 0.76
SCHEMBL17556594 0.70 CYP2D6 (0.32)
SCHEMBL256774 0.65
Aziridine SCHEMBL2267 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 14752 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250295683-A1 HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) 2025-09-25 US claimed
EP-4619406-A1 TRICYCLIC COMPOUNDS Schrödinger, Inc. (US) 2025-09-24 EP claimed
US-20250171447-A1 ADENOSINE RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS AND THEIR USE THEREOF MERCK SHARP & DOHME LLC (US) 2025-05-29 US claimed
US-20250161462-A1 ENDOSOMAL CLEAVABLE HYDROPHILIC-MASKED CATIONIC CHARGE DELIVERY VEHICLES UNIV CALIFORNIA (US) 2025-05-22 US claimed
EP-4527838-A1 HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) 2025-03-26 EP claimed
US-20250084416-A1 TARGETING OF XKR8 IN THERAPIES UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2025-03-13 US claimed
WO-2023221797-A9 HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 四川科伦博泰生物医药股份有限公司 2025-02-13 WO claimed
EP-3924340-B1 INDAZOLYL-ISOXAZOLE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS CANCER MERCK PATENT GMBH (DE) 2025-01-29 EP claimed
US-20240424131-A1 TARGETING NANOPARTICLES FOR THERAPY UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2024-12-26 US claimed
EP-4479056-A1 ADENOSINE RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS AND THEIR USE THEREOF Merck Sharp & Dohme LLC (US) 2024-12-25 EP claimed
US-4579737-A ANTITUMOR AGENTS BRISTOL-MYERS COMPANY (US) 1986-04-01 US claimed
EP-0171037-A2 3-Carbonyl-1-aminoalkyl-1H-indoles useful as analgesics and preparation thereof STERLING WINTHROP INC. (US) 1986-02-12 EP claimed
US-4567256-A MITOMYCINS BRISTOL-MYERS COMPANY (US) 1986-01-28 US claimed
US-4518596-A Antithrombotic use of 2-(perhydro-1,4-diazino)-pyrimido (5,4,D)-pyrimidines DR. KARL THOMAE GMBH (DE) 1985-05-21 US claimed
US-4487769-A ANTITUMOR AGENTS;MITOMYCIN DERIVATIVES BRISTOL-MYERS COMPANY (US) 1984-12-11 US claimed
EP-0023559-B1 2-(PERHYDRO-1,4-DIAZINO)-PYRIMIDO(5,4-D)PYRIMIDINES, THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM Dr. Karl Thomae GmbH (DE) 1984-09-19 EP claimed
US-4388315-A TAUTOMERIC PYRIMIDINE DERIVATIVES BOEHRINGER INGELEHEIM GMBH (DE) 1983-06-14 US claimed
US-4288437-A ANTICONVULSANTS BOEHRINGER INGELHEIM GMBH (DE) 1981-09-08 US claimed
US-4241056-A ANTIBIOTICS BOEHRINGER INGELHEIM GMBH (DE) 1980-12-23 US claimed
US-3956492-A SEDATIVES, MUSCLE RELAXANTS, TRANQUILIZERS, ANTICONVULSANTS BOEHRINGER INGELHEIM GMBH (DT) 1976-05-11 US claimed